Treatment of choroid metastasis from lung adenocarcinoma with bevacizumab-containing chemotherapy: A case report

6Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

The occurrence of ocular metastasis from lung cancer is uncommon. The present study reports the case of a 69-year-old female patient with lung adenocarcinoma who was found to have a metastatic lesion in the left choroid at the time of presentation. As the patient was found to have a mutation in the epidermal growth factor receptor, treatment with gefitinib was administered; however, the response was evaluated as a progressive disease. Thereafter, the patient received chemotherapy with carboplatin, pemetrexed and bevacizumab. Radiological imaging revealed shrinkage of the primary lesion and choroidal metastasis, and the visual power of the left eye was also shown to improve. Therefore, the present case report demonstrated the efficacy and safety of systemic bevacizumab therapy in combination with a platinum doublet for the treatment of choroid metastasis, with morphological and functional improvements observed with regard to the choroidal metastatic tumor.

Cite

CITATION STYLE

APA

Makabe, K., Kurishima, K., Shiozawa, T., Miyazaki, K., Ohara, G., Kagohashi, K., … Hizawa, N. (2016). Treatment of choroid metastasis from lung adenocarcinoma with bevacizumab-containing chemotherapy: A case report. Experimental and Therapeutic Medicine, 11(1), 239–242. https://doi.org/10.3892/etm.2015.2893

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free